InsiderTrades.com logo
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
From Banyan Hill Publishing   |   Ad
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him

PLUR Insider Trading

Insider Ownership Percentage: 24.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Pluri Insider Trading History Chart

This chart shows the insider buying and selling history at Pluri by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pluri Share Price & Price History

Current Price: $5.01
Price Change: ▼ Price Decrease of -0.24 (-4.57%)
As of 04/22/2024 01:00 AM ET

This chart shows the closing price history over time for PLUR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Pluri Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2022Zami AbermanDirectorSell250$7.76$1,940.00186,496View SEC Filing Icon  
See Full Table
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SEC Filings (Institutional Ownership Changes) for Pluri (NASDAQ:PLUR)

16.59% of Pluri stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PLUR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Pluri Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/8/2023Values First Advisors Inc.135,547$81K0.1%+168.4%0.328%Search for SEC Filing on Google Icon
8/11/2023Nia Impact Advisors LLC38,294$29K0.0%-33.5%0.093%Search for SEC Filing on Google Icon
7/6/2023Green Alpha Advisors LLC114,970$92K0.1%+92.1%0.280%Search for SEC Filing on Google Icon
5/11/2023Meitav Investment House Ltd.82,673$86K0.0%N/A0.208%Search for SEC Filing on Google Icon
5/5/2023Prime Capital Investment Advisors LLC57,862$59K0.0%N/A0.145%Search for SEC Filing on Google Icon
5/3/2023Nia Impact Advisors LLC57,595$59K0.0%-41.4%0.145%Search for SEC Filing on Google Icon
2/9/2023Nia Impact Advisors LLC98,313$92K0.1%-26.1%0.301%Search for SEC Filing on Google Icon
12/2/2022Values First Advisors Inc.48,330$38K0.0%N/A0.148%Search for SEC Filing on Google Icon
10/14/2022Green Alpha Advisors LLC56,226$44K0.0%N/A0.172%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Pluri logo
Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production. The company's development pipeline includes PLX-PAD, is composed of maternal mesenchymal stromal cells originating from the placenta that is currently under phase III study for orthopedic, phase II study for COVID-19, and phase I/II clinical study for Steroid-Refractory cGVHD indications; and PLX-R18, is composed of fetal MSC like cells originating from the placenta that is currently under phase I study for HCT and pilot study for ARS indications. It is also involved in the development of modified PLX cells. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Read More on Pluri

Today's Range

Now: $5.01
Low: $5.01
High: $5.51

50 Day Range

MA: $6.48
Low: $5.00
High: $8.16

52 Week Range

Now: $5.01
Low: $3.45
High: $8.56

Volume

8,512 shs

Average Volume

25,874 shs

Market Capitalization

$25.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45

Who are the company insiders with the largest holdings of Pluri?

Pluri's top insider investors include:
  1. Zami Aberman (Director)
Learn More about top insider investors at Pluri.
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
From Banyan Hill Publishing   |   Ad
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See how you can invest alongside him